2023
DOI: 10.1093/fampra/cmad039
|View full text |Cite
|
Sign up to set email alerts
|

Recruiting general practitioners and older patients with multimorbidity to randomized trials

Abstract: Background Older patients with multimorbidity are under-represented in experimental research. Objective To explore the barriers and facilitators to general practitioner (GP) and older patient recruitment and retention in a cluster randomized controlled trial (RCT). Method This descriptive study uses qualitative and quantitative data from a cluster RCT, design… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 36 publications
0
3
0
Order By: Relevance
“…There are, however, limitations in this study. Firstly, recruitment of general practices for research trials is challenging since they are self-employed often working on a tight schedule [ 36 ]. The study design and remuneration for participation are expected to facilitate recruitment.…”
Section: Discussionmentioning
confidence: 99%
“…There are, however, limitations in this study. Firstly, recruitment of general practices for research trials is challenging since they are self-employed often working on a tight schedule [ 36 ]. The study design and remuneration for participation are expected to facilitate recruitment.…”
Section: Discussionmentioning
confidence: 99%
“…Older people are often excluded from clinical trials due to advanced age, multimorbidity, and/or frailty [ 1 ]. Recruitment and retention of older participants are important challenges.…”
Section: Introductionmentioning
confidence: 99%
“…Cognitive decline is common, and proxies or next-to-kin are often needed to consent. Older participants have an increased risk of dropping out of trials, and several other pitfalls may result in both underestimating and overestimating the intervention effects [ 1 ]. Despite these obstacles, it is important to include elderly individuals in clinical trials.…”
Section: Introductionmentioning
confidence: 99%